126 related articles for article (PubMed ID: 36542958)
21. The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients.
Hansen L; Ekstrøm CT; Tabanera Y Palacios R; Anant M; Wassermann K; Reinhardt RR
J Clin Endocrinol Metab; 2006 Sep; 91(9):3446-50. PubMed ID: 16822823
[TBL] [Abstract][Full Text] [Related]
22. Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors.
Li X; Anderson M; Collin D; Muegge I; Wan J; Brennan D; Kugler S; Terenzio D; Kennedy C; Lin S; Labadia ME; Cook B; Hughes R; Farrow NA
J Biol Chem; 2017 Jul; 292(28):11618-11630. PubMed ID: 28546429
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis.
Kaur S; Nag A; Gangenahalli G; Sharma K
Front Genet; 2019; 10():554. PubMed ID: 31263479
[TBL] [Abstract][Full Text] [Related]
24. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
[TBL] [Abstract][Full Text] [Related]
25. A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.
Brust R; Shang J; Fuhrmann J; Mosure SA; Bass J; Cano A; Heidari Z; Chrisman IM; Nemetchek MD; Blayo AL; Griffin PR; Kamenecka TM; Hughes TS; Kojetin DJ
Nat Commun; 2018 Nov; 9(1):4687. PubMed ID: 30409975
[TBL] [Abstract][Full Text] [Related]
26. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison).
Desmarais JA; Lopes FL; Zhang H; Das SK; Murphy BD
Biol Reprod; 2007 Nov; 77(5):829-39. PubMed ID: 17615406
[TBL] [Abstract][Full Text] [Related]
27. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.
Lüdtke A; Buettner J; Schmidt HH; Worman HJ
J Med Genet; 2007 Sep; 44(9):e88. PubMed ID: 17766367
[TBL] [Abstract][Full Text] [Related]
28. [Peroxisome proliferator activated receptor gamma activation and overexpression prevent hepatocellular apoptosis of nutritional fibrotic steatohepatitis in mice].
Nan YM; Han F; Kong LB; Li Y; Wang RQ; Zhao SX
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):521-6. PubMed ID: 22152244
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.
Blitek A; Szymanska M
Theriogenology; 2017 Oct; 101():53-61. PubMed ID: 28708516
[TBL] [Abstract][Full Text] [Related]
30. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability.
Bruedigam C; Koedam M; Chiba H; Eijken M; van Leeuwen JP
FEBS Lett; 2008 May; 582(11):1618-24. PubMed ID: 18435931
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
32. The importance of the nuclear positioning of the PPARG gene for its expression during porcine in vitro adipogenesis.
Stachecka J; Nowacka-Woszuk J; Kolodziejski PA; Szczerbal I
Chromosome Res; 2019 Sep; 27(3):271-284. PubMed ID: 30656515
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.
Goto K; Iso T; Hanaoka H; Yamaguchi A; Suga T; Hattori A; Irie Y; Shinagawa Y; Matsui H; Syamsunarno MR; Matsui M; Haque A; Arai M; Kunimoto F; Yokoyama T; Endo K; Gonzalez FJ; Kurabayashi M
J Am Heart Assoc; 2013 Jan; 2(1):e004861. PubMed ID: 23525438
[TBL] [Abstract][Full Text] [Related]
34. Activation of PPARγ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
Mehus AA; Bergum N; Knutson P; Shrestha S; Zhou XD; Garrett SH; Sens DA; Sens MA; Somji S
PLoS One; 2020; 15(8):e0237976. PubMed ID: 32822399
[TBL] [Abstract][Full Text] [Related]
35. A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-gamma nuclear translocation.
Kawai M; Green CB; Lecka-Czernik B; Douris N; Gilbert MR; Kojima S; Ackert-Bicknell C; Garg N; Horowitz MC; Adamo ML; Clemmons DR; Rosen CJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10508-13. PubMed ID: 20498072
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-27a/b-3p and PPARG regulate SCAMP3 through a feed-forward loop during adipogenesis.
Kulyté A; Kwok KHM; de Hoon M; Carninci P; Hayashizaki Y; Arner P; Arner E
Sci Rep; 2019 Sep; 9(1):13891. PubMed ID: 31554889
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach.
D'Aniello E; Fellous T; Iannotti FA; Gentile A; Allarà M; Balestrieri F; Gray R; Amodeo P; Vitale RM; Di Marzo V
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):586-597. PubMed ID: 30611848
[TBL] [Abstract][Full Text] [Related]
38. A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer.
Tortora D; Roberts ME; Kumar G; Kotapalli SS; Ritch E; Scurll JM; McConeghy B; Sinha S; Wyatt AW; Black PC; Daugaard M
iScience; 2023 May; 26(5):106525. PubMed ID: 37250326
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-Δ
Gómez-Abellán V; Pérez-Oliva AB; Cabas I; Hermi F; Arizcun M; García-Moreno D; Sepulcre MP; Mulero V
Dev Comp Immunol; 2022 Nov; 136():104498. PubMed ID: 35948178
[TBL] [Abstract][Full Text] [Related]
40. An Asp7Gly substitution in PPARG is associated with decreased transcriptional activation activity.
Hua L; Wang J; Li M; Sun X; Zhang L; Lei C; Lan X; Fang X; Zhao X; Chen H
PLoS One; 2014; 9(1):e86954. PubMed ID: 24466299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
